Re: AACR April 24-29, 2020 for some Zenith Clinical Trial Results?
in response to
by
posted on
Apr 19, 2020 08:38PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
They will have preliminary Phase 1a results from the TNBC study with Pfizer (which started in June 2019?) but they will sit on those for the summer, at a minimum, so don't expect anything in either April or June. Given that the FDA has not stopped the study, perhaps none of the initial tranche of 5-10? seriously ill people have died to date. Perhaps they are all feeling much better. Would also be nice to know how many patients have been treated to date.